What is thrombolytic therapy for middle cerebral artery (MCA) stroke?

Updated: Mar 17, 2020
  • Author: Daniel I Slater, MD; Chief Editor: Stephen Kishner, MD, MHA  more...
  • Print


Thrombolytic therapy should be administered in a very orchestrated and consistent manner, relying on emergent imaging and screening to ensure only patients with ischemic stroke and no contraindications receive such therapy. After ischemic stroke, patients should be discharged from acute care on a statin, antihypertensive, and appropriate antithrombotic and/or anticoagulation medicines to prevent recurrent stroke. The selection of such medications is dependent on the presence of comorbidities, including atrial fibrillation, coronary artery disease, congestive heart failure, and diabetes.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!